Loose-dose Combination of Acarbose and Metformin for T2DM in Metformin-failure Patients
Status:
Completed
Trial end date:
2019-08-21
Target enrollment:
Participant gender:
Summary
To demonstrate the efficacy and safety of acarbose and metformin loose-dose combination as
compared to metformin monotherapy in the treatment of subjects with T2DM that is inadequately
controlled by metformin alone